9,10-dimethyl-1,2-benzanthracene has been researched along with temarotene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bollag, W; Hartmann, HR | 1 |
| Bollag, W; Teelmann, K | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and temarotene
| Article | Year |
|---|---|
Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Female; Fenretinide; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids; Time Factors; Tretinoin | 1987 |
Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Retinoids; Tamoxifen | 1988 |